Previous 10 | Next 10 |
2023-06-07 11:51:09 ET Amarin Corporation plc (AMRN) Jefferies 2023 Global Healthcare Conference June 7, 2023 8:00 AM ET Company Participants Aaron Berg - Interim CEO & President Tom Reilly - CFO Conference Call Participants Michael Yee - Jefferies ...
2023-06-02 15:00:55 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week, or the Seeking Alpha earnings calendar ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) as an Adjunct to Diet to Reduce Triglyceride Levels in Adult Patients with Severe Hypertriglyceridemia (≥ 500 mg/dL) -- -- EddingPharm Now Working Towards Preparing for Commercial Launch of VASCEPA Across ...
2023-05-23 09:50:41 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks have gotten caught up in the broader technology sector sell-off. The benchmark iShares Biotechnology ETF (NYSEARCA: IBB ) has fallen from a peak of ...
— New Research Demonstrates Multifactorial Beneficial Effects of VASCEPA/VAZKEPA on Coronary Physiology and Plaque Progression — --Data Further Advances Understanding of VASCEPA/VAZKEPA Potential Mechanism of Action-- DUBLIN, Ireland and BRIDGEWATER, N.J., May 12, 20...
2023-05-08 18:00:12 ET Alkermes' ( NASDAQ: ALKS ) board said that they declined to endorse any of Sarissa Capital Management's three nominees after conducting interviews. The board said it is hoping to find a resolution that would avoid a contested election and proxy battle. ...
2023-05-03 14:00:53 ET Image source: The Motley Fool. Amarin Plc (NASDAQ: AMRN) Q1 2023 Earnings Call May 03, 2023 , 8:00 a.m. ET Operator Continue reading For further details see: Amarin Plc (AMRN) Q1 2023 Earnings Call Transcript
2023-05-03 10:03:02 ET Amarin Corporation plc (AMRN) Q1 2023 Earnings Conference Call May 03, 2023, 08:00 AM ET Company Participants Lisa DeFrancesco - Senior Vice President, Corporate Affairs and Investor Relations Aaron Berg - Interim President & Chief Executiv...
2023-05-03 09:24:24 ET Amarin Corporation ( NASDAQ: AMRN ) reported better than expected financials for Q1 2023 on Wednesday, even as its topline contracted ~9% YoY amid generic competition to its fish oil-derived heart disease therapy Vazkepa. The Ireland-based biotech posted $...
2023-05-03 07:02:25 ET Amarin press release ( NASDAQ: AMRN ): Q1 Non-GAAP EPS of -$0.02 misses by $0.01 . Revenue of $85.7M (-9.4% Y/Y) beats by $4.47M . For further details see: Amarin Non-GAAP EPS of -$0.02 misses by $0.01, revenue of $85.7M beats by $4...
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...